Yubo International Biotech Ltd is a U. S. holding company primarily operating through its wholly owned subsidiary, Platinum International Biotech Co., Ltd., a company organized under the laws of the Cayman Islands. Platinum, in turn, operates in China through its subsidiaries and contractual arrangements with a variable interest entity, Yubo International Biotech (Beijing) Limited, a company organized under the laws of the People’s Republic of China. Yubo Beijing conducts…
Yubo International Biotech Ltd is a U. S. holding company primarily operating through its wholly owned subsidiary, Platinum International Biotech Co., Ltd., a company organized under the laws of the Cayman Islands. Platinum, in turn, operates in China through its subsidiaries and contractual arrangements with a variable interest entity, Yubo International Biotech (Beijing) Limited, a company organized under the laws of the People’s Republic of China. Yubo Beijing conducts the day-to-day business operations of the company in China through contractual arrangements with the subsidiaries of Platinum. The company is focused on the research and development and application of endometrial stem cells, committed to building the first public endometrial stem cell repository in the world. Its operations are centered on healthcare products and services derived from stem cell technology, with activities spanning product development, testing, and health management consulting.
Yubo Beijing offers its products and services under the brand “VIVCELL.” The product offerings include healthcare products for the respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products. Additionally, Yubo Beijing provides stem cell related services such as cell testing and health management consulting services. Revenue generation is derived from the sale of these healthcare and personal care products, as well as fees from stem cell testing and consulting services. The company serves individual consumers seeking wellness and personal care solutions through its branded product lines and service offerings.
The company operates through the following segments:
- Stem Cell Research and Development: This segment focuses on the scientific investigation and application of endometrial stem cells for therapeutic and regenerative purposes. Activities include laboratory research, cell cultivation, and the development of stem cell-based technologies. The segment aims to establish a public endometrial stem cell repository to support future medical and commercial applications.
- Healthcare and Personal Care Products: This segment encompasses the formulation, production, and distribution of consumer health and wellness products under the VIVCELL brand. Product lines include respiratory healthcare items, skincare formulations, hair care solutions, nutritional beverages, and gender-specific personal care goods. The VIVCELL trademark is prominently featured across all product packaging and marketing materials to ensure brand consistency and consumer recognition.
- Stem Cell Testing and Health Management Consulting: This segment provides diagnostic and advisory services related to stem cell health and overall wellness. Services include laboratory-based cell testing to assess viability and potency, as well as personalized health management consultations for clients seeking preventive or regenerative care. The consulting arm integrates scientific findings from the research segment with practical health guidance for end users.
Yubo International Biotech Ltd operates in the competitive biotechnology and consumer wellness industry, where it differentiates itself through its focus on endometrial stem cell technology—a niche area with limited direct competitors. The company’s competitive advantage lies in its proprietary research, the VIVCELL brand, and its integrated model that connects stem cell science with consumer-facing health products and services. While broader biotech firms may focus on pharmaceuticals or industrial applications, Yubo Beijing targets the consumer wellness market with biologically derived offerings, positioning itself at the intersection of advanced cell therapy and everyday health maintenance.
The company’s customer base consists primarily of individual consumers interested in preventive health, skincare, hair care, respiratory wellness, and personal care products. These customers seek science-backed wellness solutions and are likely drawn to the innovative stem cell foundation of the VIVCELL product lines. Additionally, clients utilizing stem cell testing and health management consulting services are typically health-conscious individuals seeking personalized insights into their cellular wellness and long-term vitality. No specific customer names are disclosed in the filing, so the base is described by type rather than named entities.